HOUSTON, TEXAS May. 16, 2007. Pharm-Olam International Ltd. (POI), a multi-national, full service CRO to pharmaceutical and biotech industries will host complimentary seminars on conducting clinical trials in India and Romania. The seminar will focus on recent changes of interest in these two nations and will be held in La Jolla on May 29, San Francisco on May 31, and Cambridge, MA on June 6. Dr. Radhika Bobba from Bangalore, India will present information concerning the potential of India for drug development including, how India differs from other world markets, how to take advantage of recent changes in regulatory approval, enforced patent protection, and the growing market for research across a variety of therapeutic areas. Dr. Ramona Nicolescu from Bucharest, Romania will discuss how Romania's transition into the European Union impacts clinical trials, the population's therapeutic needs, medical infrastructure , and the regulatory process of Romania. For further information about conducting trials with Pharm-Olam please contact jhovre@pharm-olam.com About Pharm-Olam International Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, POI focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.
|